Literature DB >> 6341480

Shigella infections in the United States, 1974-1980.

M J Blaser, R A Pollard, R A Feldman.   

Abstract

During the seven-year period 1974-1980, 93,516 Shigella isolates from humans were reported to the Centers for Disease Control, Atlanta, through a nationwide surveillance system. Over the past 30 years, the reported incidence of shigellosis has been declining in contrast to that reported for salmonellosis. Shigella sonnei (group D) now accounts for approximately 70% of the Shigella isolates reported, since most of the decline has been due to the increasingly less frequent infections caused by Shigella flexneri (group B); Shigella dysenteriae infections are now uncommon. The highest reported rates of shigellosis are from the western states and among children from one to five years of age. Among the total population of the United States, the ratio of S. flexneri to S. sonnei isolates was 0.28 among persons from one to 19 years of age and 0.45 among persons greater than or equal to 20 years of age; among American Indians the proportion of S. flexneri was much greater, the corresponding ratios being 2.1 and 2.9, respectively; in both groups the ratios for children younger than one year of age resembled those obtaining for adults. Age-related acquisition of immunity to S. sonnei may explain these observations.

Entities:  

Mesh:

Year:  1983        PMID: 6341480     DOI: 10.1093/infdis/147.4.771

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Retrospective analysis of the first clonal outbreak of nalidixic acid-resistant Shigella sonnei shigellosis in Israel.

Authors:  D Dagan; N Orr; M Yavzori; Y Yuhas; D Meron; S Ashkenazi; D Cohen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-12-10       Impact factor: 3.267

2.  Shigellosis on Indian reserves in Manitoba, Canada: its relationship to crowded housing, lack of running water, and inadequate sewage disposal.

Authors:  T Rosenberg; O Kendall; J Blanchard; S Martel; C Wakelin; M Fast
Journal:  Am J Public Health       Date:  1997-09       Impact factor: 9.308

3.  Community-based safety, immunogenicity, and transmissibility study of the Shigella sonnei WRSS1 vaccine in Israeli volunteers.

Authors:  Nadav Orr; David E Katz; Jacob Atsmon; Paull Radu; Miri Yavzori; Tamar Halperin; Tamar Sela; Raid Kayouf; Zivit Klein; Ruhama Ambar; Dani Cohen; Marcia K Wolf; Malabi M Venkatesan; Thomas L Hale
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

4.  Characterization of Shigella strains in Iran by plasmid profile analysis and PCR amplification of ipa genes.

Authors:  Shohreh Farshad; Raheleh Sheikhi; Aziz Japoni; Ezzatollah Basiri; Abdolvahab Alborzi
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

5.  Molecular epidemiology of a Shigella flexneri outbreak in a mountainous township in Taiwan, Republic of China.

Authors:  C S Chiou; W B Hsu; H L Wei; J H Chen
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

6.  Cytotoxicity of human peripheral blood and colostral leukocytes against Shigella species.

Authors:  D R Morgan; H L DuPont; B Gonik; S Kohl
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

7.  Drug resistance and plasmid profile of shigellae in Taiwan.

Authors:  S R Lin; S F Chang
Journal:  Epidemiol Infect       Date:  1992-02       Impact factor: 2.451

8.  Three-year prospective study of intestinal pathogens in Madrid, Spain.

Authors:  A C Velasco; M L Mateos; G Más; A Pedraza; M Díez; A Gutiérrez
Journal:  J Clin Microbiol       Date:  1984-08       Impact factor: 5.948

9.  Use of multiple markers for investigation of an epidemic of Shigella sonnei infections in Monroe County, New York.

Authors:  P Yagupsky; M Loeffelholz; K Bell; M A Menegus
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

10.  Identification of Shigella species in stool specimens by DNA amplification of different loci of the Shigella virulence plasmid.

Authors:  M Yavzori; D Cohen; R Wasserlauf; R Ambar; G Rechavi; S Ashkenazi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-03       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.